Chronic Disease Management Market Report 2026

The chronic disease management market size has grown exponentially in recent years. It will grow from $11.3 billion in 2025 to $13.73 billion in 2026 at a compound annual growth rate (CAGR) of 21.6%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing healthcare digitization initiatives, growth in aging population, early adoption of electronic health records, expansion of telehealth infrastructure.

The chronic disease management market size is expected to see exponential growth in the next few years. It will grow to $29.55 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to increasing demand for value-based care models, rising adoption of remote patient monitoring solutions, expansion of cloud-based healthcare platforms, growing focus on patient engagement tools, increasing investments in digital health ecosystems. Major trends in the forecast period include increasing adoption of ai-driven patient monitoring tools, rising use of remote care management platforms, growing integration of data analytics in disease tracking, expansion of personalized care management programs, enhanced focus on preventive care workflows.

The increasing prevalence of chronic disorders is anticipated to drive the growth of the chronic disease management market in the coming years. A chronic disease is defined as a condition that persists for three months or longer and may worsen over time. The growing burden of chronic diseases is largely attributed to factors such as aging populations, sedentary lifestyles, and increased life expectancy. The chronic disease management market addresses this need by offering remote monitoring, personalized medicine, and data-driven technologies that support the long-term management of such conditions. For example, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, 76.4% of adults (194 million) in 2023 had at least one chronic condition, while 51.4% (130 million) were living with multiple chronic conditions. Consequently, the rising prevalence of chronic disorders is fueling the growth of the chronic disease management market.

Key companies operating in the chronic disease management market are prioritizing the development of advanced solutions, including integrated digital care platforms, to strengthen patient engagement, improve treatment adherence, and enhance health outcomes. Integrated digital care platforms are technology-enabled systems that combine remote monitoring, personalized coaching, and data analytics to help patients manage chronic conditions more effectively. For instance, in January 2024, Amazon, a U.S.-based technology and healthcare company, partnered with Omada Health, a U.S.-based provider of digital health programs, to deliver a comprehensive chronic condition management solution. This program offers continuous support for patients with conditions such as diabetes, hypertension, and heart disease by integrating real-time health monitoring, virtual coaching, and personalized care plans. By utilizing data-driven insights and connected care solutions, this initiative empowers patients, supports clinical decision-making, and contributes to improved long-term health outcomes.

In February 2025, Teladoc Health, a U.S.-based virtual care and chronic condition platform provider, acquired Catapult Health for an undisclosed amount. Through this acquisition, Teladoc aims to strengthen its chronic condition and at-home diagnostics capabilities, expanding its ecosystem for chronic disease management, including monitoring, prevention, and home-based diagnostics, while aligning with the broader growth of digital chronic care services. Catapult Health is a U.S.-based provider of preventive healthcare and worksite-based health checkups, offering virtual consultations and diagnostic blood testing services.

Major companies operating in the chronic disease management market are Veradigm Inc.; ScienceSoft USA Corporation; Siemens Healthcare Private Limited; Infosys Limited; MINES and Associates Inc.; Biofourmis Care Solutions Pte. Ltd.; i2i Systems Inc.; Phytel Inc.; Wellcentive Inc.; TriZetto Corporation; Mediware Human & Social Services Inc.; Pegasystems Inc.; ZeOmega Inc.; Cigniti Technologies Limited; Health Catalyst; Cedar Gate Technologies; Epic Systems Corporation; Hinduja Global Solutions Ltd.; NXGN Management LLC; Casenet LLC; EXLService Holdings Inc.; cliexa Inc.; Vivify Health Inc.; WellSky; Healthy.io; Optum Inc.; Omada Health.

North America was the largest region in the chronic disease management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic disease management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chronic disease management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the chronic disease management market by increasing costs of imported medical devices, connected monitoring hardware, data servers, and software infrastructure used in digital care platforms. Healthcare providers in North America and Europe are most affected due to reliance on imported technology components, while Asia-Pacific faces higher costs for cloud infrastructure expansion. These tariffs are increasing implementation costs and slowing platform upgrades. However, they are also encouraging domestic software development, regional health IT ecosystems, and localized deployment of chronic care management solutions.

The chronic disease management market research report is one of a series of new reports that provides chronic disease management market statistics, including chronic disease management industry global market size, regional shares, competitors with a chronic disease management market share, detailed chronic disease management market segments, market trends and opportunities, and any further data you may need to thrive in the chronic disease management industry. This chronic disease management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic disease management refer to software and tools used to manage the symptoms of long-term conditions and delay the advancement of chronic conditions to ensure the safety of life.

The chronic disease management solutions are deployed through on-premises, cloud-based or web-based platforms. The on-premises deployment of chronic disease management solutions and services refers to software solutions and tools that are implemented in-house and as part of an organization's IT infrastructure, where the solution, as well as any connected procedures, are the responsibility of the enterprise. They are used for the management of different diseases which includes cardiovascular diseases, diabetes, cancer, asthma, and chronic obstructive pulmonary disorders. The services in chronic disease management include consulting services, implementation services, and educational services. Chronic disease management services are utilized by both providers and payers.

The chronic disease management market includes revenues earned by entities by providing illness management screenings services, check-ups, treatment monitoring and coordination, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.